The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/36288
StudyName: Eligibility Lymphoma NCT01974440
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 30.04.2019
License: Creative Commons BY 4.0

----

Description: 
A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01974440
